2023-2027 年全球核医学市场

这份报告监测了核医学市场，预计2022年至2027年间将增长80.5789亿美元，预测期内復合年增长率为16.48%。我预测。

本报告提供了全面分析、市场规模和预测、趋势、增长动力和挑战，以及涵盖核医学市场大约 25 家供应商的供应商分析。

我们提供对当前市场情况、最新趋势和驱动因素以及整体市场环境的最新分析。 SPECT/CT 混合成像系统的日益普及、越来越多地使用核医学进行疾病早期检测、癌症患者数量不断增加以及对癌症市场的投资不断增加，推动了该市场的发展。

该研究指出，与放射性药物的潜在益处相比，副作用更少，这是推动未来几年核医学市场增长的主要原因之一。 我们也相信，扩大混合成像应用的研发、不断发现和开发新的放射性药物将导致巨大的市场需求。

内容

第 1 章执行摘要

• 市场概览

第二章市场状况

• 市场生态系统

第三章市场规模

• 市场定义
• 市场分析
• 2022 年市场规模
• 2022-2027 年市场展望

第 4 章市场规模结果

• 2017-2021 年全球核医学市场
• 2017-2021 年产品细分分析
• 2017-2021 年应用分析
• 2017-2021 年各地区分析
• 2017-2021 年国家/地区分析

第五章五力分析

• 五力总结
• 买家的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场

第 6 章市场细分：按产品

• 市场细分
• 比较：按产品
• 放射肿瘤学：2022-2027 年市场规模和预测
• 设备（SPECT、PET）：2022-2027 年市场规模和预测
• 市场机会：按产品分类

第 7 章市场细分：按应用

• 市场细分
• 比较：按应用
• 肿瘤学：2022-2027 年市场规模和预测
• 心脏病学：2022-2027 年市场规模和预测
• 神经：市场规模和 2022-2027 年预测
• 其他：2022-2027 年市场规模和预测
• 市场机会：按应用

第八章客户情况

• 客户情况总结

第九章区域情况

• 区域细分
• 按地区比较
• 北美：2022-2027 年市场规模和预测
• 亚洲：2022-2027 年市场规模和预测
• 欧洲：2022-2027 年市场规模和预测
• 世界其他地区：2022-2027 年市场规模和预测
• 美国：2022-2027 年市场规模和预测
• 日本：2022-2027 年市场规模和预测
• 中国：2022-2027 年市场规模和预测
• 德国：2022-2027 年市场规模和预测
• 英国：2022-2027 年市场规模和预测
• 各地区的市场机会

第 10 章驱动因素、挑战和趋势

• 市场驱动力
• 市场挑战
• 挑战的驱动因素和影响
• 市场趋势

第 11 章供应商概况

• 概览
• 供应商情况
• 混乱情况
• 行业风险

第 12 章供应商分析

• 目标供应商
• 供应商市场定位
• Bayer AG
• Bracco Spa
• Cardinal Health Inc.
• Eckert and Ziegler AG
• ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
• GE Healthcare Technologies Inc.
• IBA Radiopharma Solutions
• Jubilant Pharmova Ltd.
• Koninklijke Philips NV
• Mallinckrodt Plc
• Medi-Radiopharma
• Necsa
• Novartis AG
• Siemens Healthineers AG
• Sirtex Medical Pty Ltd.

第13章 附录

Technavio has been monitoring the nuclear medicine market and is forecast to grow by $8057.89 mn during 2022-2027, accelerating at a CAGR of 16.48% during the forecast period. Our report on the nuclear medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of SPECT/CT hybrid imaging systems, increased use of nuclear medicine for detecting diseases at an early stage, and growing cancer cases and rising investment in the oncology market.

Technavio's nuclear medicine market is segmented as below:

By Product

• Radiotherapeutics
• Equipment SPECT and PET

By Application

• Oncology
• Cardiology
• Neurology
• Others

By Geographical Landscape

• North America
• Asia
• Europe
• Rest of World (ROW)

This study identifies the minimal side effects of radiopharmaceuticals as compared with their potential benefits as one of the prime reasons driving the nuclear medicine market growth during the next few years. Also, growing research activities to widen the applications of hybrid imaging and the constant discovery and development of new radiopharmaceuticals will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the nuclear medicine market covers the following areas:

• Nuclear medicine market sizing
• Nuclear medicine market forecast
• Nuclear medicine market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading nuclear medicine market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Eckert and Ziegler AG, ECZACIBASI MONROL NUCLEAR PRODUCTS CO., GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Koninklijke Philips NV, Lantheus Holdings Inc., Mallinckrodt Plc, Medi-Radiopharma , Mirion Technologies Inc., Necsa, Novartis AG, Siemens Healthineers AG, Sirtex Medical Pty Ltd., Telix Pharmaceuticals Ltd., Tema Sinergie SpA, and TTG Imaging Solutions LLC. Also, the nuclear medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global nuclear medicine market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
• 4.2 Product Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.3 Application Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Radiotherapeutics - Market size and forecast 2022-2027
• Exhibit 34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
• 6.4 Equipment (SPECT and PET) - Market size and forecast 2022-2027
• Exhibit 38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Product
• Exhibit 42: Market opportunity by Product ($ million)
• Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 44: Chart on Application - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
• 7.2 Comparison by Application
• Exhibit 46: Chart on Comparison by Application
• Exhibit 47: Data Table on Comparison by Application
• 7.3 Oncology - Market size and forecast 2022-2027
• Exhibit 48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
• 7.4 Cardiology - Market size and forecast 2022-2027
• Exhibit 52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
• 7.5 Neurology - Market size and forecast 2022-2027
• Exhibit 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
• 7.6 Others - Market size and forecast 2022-2027
• Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by Application
• Exhibit 64: Market opportunity by Application ($ million)
• Exhibit 65: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Asia - Market size and forecast 2022-2027
• Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.5 Europe - Market size and forecast 2022-2027
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Japan - Market size and forecast 2022-2027
• Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.9 China - Market size and forecast 2022-2027
• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.10 Germany - Market size and forecast 2022-2027
• Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ million)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Bayer AG
• Exhibit 115: Bayer AG - Overview
• Exhibit 116: Bayer AG - Business segments
• Exhibit 117: Bayer AG - Key news
• Exhibit 118: Bayer AG - Key offerings
• Exhibit 119: Bayer AG - Segment focus
• 12.4 Bracco Spa
• Exhibit 120: Bracco Spa - Overview
• Exhibit 121: Bracco Spa - Product / Service
• Exhibit 122: Bracco Spa - Key offerings
• 12.5 Cardinal Health Inc.
• Exhibit 123: Cardinal Health Inc. - Overview
• Exhibit 124: Cardinal Health Inc. - Business segments
• Exhibit 125: Cardinal Health Inc. - Key news
• Exhibit 126: Cardinal Health Inc. - Key offerings
• Exhibit 127: Cardinal Health Inc. - Segment focus
• 12.6 Eckert and Ziegler AG
• Exhibit 128: Eckert and Ziegler AG - Overview
• Exhibit 129: Eckert and Ziegler AG - Business segments
• Exhibit 130: Eckert and Ziegler AG - Key news
• Exhibit 131: Eckert and Ziegler AG - Key offerings
• Exhibit 132: Eckert and Ziegler AG - Segment focus
• 12.7 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
• Exhibit 133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
• Exhibit 134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
• Exhibit 135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
• 12.8 GE Healthcare Technologies Inc.
• Exhibit 136: GE Healthcare Technologies Inc. - Overview
• Exhibit 137: GE Healthcare Technologies Inc. - Business segments
• Exhibit 138: GE Healthcare Technologies Inc. - Key offerings
• Exhibit 139: GE Healthcare Technologies Inc. - Segment focus
• 12.9 IBA Radiopharma Solutions
• Exhibit 140: IBA Radiopharma Solutions - Overview
• Exhibit 141: IBA Radiopharma Solutions - Business segments
• Exhibit 142: IBA Radiopharma Solutions - Key offerings
• Exhibit 143: IBA Radiopharma Solutions - Segment focus
• 12.10 Jubilant Pharmova Ltd.
• Exhibit 144: Jubilant Pharmova Ltd. - Overview
• Exhibit 145: Jubilant Pharmova Ltd. - Business segments
• Exhibit 146: Jubilant Pharmova Ltd. - Key news
• Exhibit 147: Jubilant Pharmova Ltd. - Key offerings
• Exhibit 148: Jubilant Pharmova Ltd. - Segment focus
• 12.11 Koninklijke Philips NV
• Exhibit 149: Koninklijke Philips NV - Overview
• Exhibit 150: Koninklijke Philips NV - Business segments
• Exhibit 151: Koninklijke Philips NV - Key news
• Exhibit 152: Koninklijke Philips NV - Key offerings
• Exhibit 153: Koninklijke Philips NV - Segment focus
• 12.12 Mallinckrodt Plc
• Exhibit 154: Mallinckrodt Plc - Overview
• Exhibit 155: Mallinckrodt Plc - Business segments
• Exhibit 156: Mallinckrodt Plc - Key news
• Exhibit 157: Mallinckrodt Plc - Key offerings
• Exhibit 158: Mallinckrodt Plc - Segment focus
• 12.13 Medi-Radiopharma
• Exhibit 159: Medi-Radiopharma - Overview
• Exhibit 160: Medi-Radiopharma - Product / Service
• Exhibit 161: Medi-Radiopharma - Key offerings
• 12.14 Necsa
• Exhibit 162: Necsa - Overview
• Exhibit 163: Necsa - Product / Service
• Exhibit 164: Necsa - Key offerings
• 12.15 Novartis AG
• Exhibit 165: Novartis AG - Overview
• Exhibit 166: Novartis AG - Business segments
• Exhibit 167: Novartis AG - Key offerings
• Exhibit 168: Novartis AG - Segment focus
• 12.16 Siemens Healthineers AG
• Exhibit 169: Siemens Healthineers AG - Overview
• Exhibit 170: Siemens Healthineers AG - Business segments
• Exhibit 171: Siemens Healthineers AG - Key news
• Exhibit 172: Siemens Healthineers AG - Key offerings
• Exhibit 173: Siemens Healthineers AG - Segment focus
• 12.17 Sirtex Medical Pty Ltd.
• Exhibit 174: Sirtex Medical Pty Ltd. - Overview
• Exhibit 175: Sirtex Medical Pty Ltd. - Product / Service
• Exhibit 176: Sirtex Medical Pty Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 179: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources
• 13.5 List of abbreviations
• Exhibit 183: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Product - Market share 2022-2027 (%)
• Exhibits31: Data Table on Product - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Product ($ million)
• Exhibits43: Data Table on Market opportunity by Product ($ million)
• Exhibits44: Chart on Application - Market share 2022-2027 (%)
• Exhibits45: Data Table on Application - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Application
• Exhibits47: Data Table on Comparison by Application
• Exhibits48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits64: Market opportunity by Application ($ million)
• Exhibits65: Data Table on Market opportunity by Application ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits107: Market opportunity By Geographical Landscape ($ million)
• Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits109: Impact of drivers and challenges in 2022 and 2027
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: Bayer AG - Overview
• Exhibits116: Bayer AG - Business segments
• Exhibits117: Bayer AG - Key news
• Exhibits118: Bayer AG - Key offerings
• Exhibits119: Bayer AG - Segment focus
• Exhibits120: Bracco Spa - Overview
• Exhibits121: Bracco Spa - Product / Service
• Exhibits122: Bracco Spa - Key offerings
• Exhibits123: Cardinal Health Inc. - Overview
• Exhibits124: Cardinal Health Inc. - Business segments
• Exhibits125: Cardinal Health Inc. - Key news
• Exhibits126: Cardinal Health Inc. - Key offerings
• Exhibits127: Cardinal Health Inc. - Segment focus
• Exhibits128: Eckert and Ziegler AG - Overview
• Exhibits129: Eckert and Ziegler AG - Business segments
• Exhibits130: Eckert and Ziegler AG - Key news
• Exhibits131: Eckert and Ziegler AG - Key offerings
• Exhibits132: Eckert and Ziegler AG - Segment focus
• Exhibits133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
• Exhibits134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
• Exhibits135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
• Exhibits136: GE Healthcare Technologies Inc. - Overview
• Exhibits137: GE Healthcare Technologies Inc. - Business segments
• Exhibits138: GE Healthcare Technologies Inc. - Key offerings
• Exhibits139: GE Healthcare Technologies Inc. - Segment focus
• Exhibits140: IBA Radiopharma Solutions - Overview
• Exhibits141: IBA Radiopharma Solutions - Business segments
• Exhibits142: IBA Radiopharma Solutions - Key offerings
• Exhibits143: IBA Radiopharma Solutions - Segment focus
• Exhibits144: Jubilant Pharmova Ltd. - Overview
• Exhibits145: Jubilant Pharmova Ltd. - Business segments
• Exhibits146: Jubilant Pharmova Ltd. - Key news
• Exhibits147: Jubilant Pharmova Ltd. - Key offerings
• Exhibits148: Jubilant Pharmova Ltd. - Segment focus
• Exhibits149: Koninklijke Philips NV - Overview
• Exhibits150: Koninklijke Philips NV - Business segments
• Exhibits151: Koninklijke Philips NV - Key news
• Exhibits152: Koninklijke Philips NV - Key offerings
• Exhibits153: Koninklijke Philips NV - Segment focus
• Exhibits154: Mallinckrodt Plc - Overview
• Exhibits155: Mallinckrodt Plc - Business segments
• Exhibits156: Mallinckrodt Plc - Key news
• Exhibits157: Mallinckrodt Plc - Key offerings
• Exhibits158: Mallinckrodt Plc - Segment focus
• Exhibits159: Medi-Radiopharma - Overview
• Exhibits160: Medi-Radiopharma - Product / Service
• Exhibits161: Medi-Radiopharma - Key offerings
• Exhibits162: Necsa - Overview
• Exhibits163: Necsa - Product / Service
• Exhibits164: Necsa - Key offerings
• Exhibits165: Novartis AG - Overview
• Exhibits166: Novartis AG - Business segments
• Exhibits167: Novartis AG - Key offerings
• Exhibits168: Novartis AG - Segment focus
• Exhibits169: Siemens Healthineers AG - Overview
• Exhibits170: Siemens Healthineers AG - Business segments
• Exhibits171: Siemens Healthineers AG - Key news
• Exhibits172: Siemens Healthineers AG - Key offerings
• Exhibits173: Siemens Healthineers AG - Segment focus
• Exhibits174: Sirtex Medical Pty Ltd. - Overview
• Exhibits175: Sirtex Medical Pty Ltd. - Product / Service
• Exhibits176: Sirtex Medical Pty Ltd. - Key offerings
• Exhibits177: Inclusions checklist
• Exhibits178: Exclusions checklist
• Exhibits179: Currency conversion rates for US$
• Exhibits180: Research methodology
• Exhibits181: Validation techniques employed for market sizing
• Exhibits182: Information sources
• Exhibits183: List of abbreviations